Brainwave

Brainwave Healthcare is a pharmaceutical company based in India that specializes in the development and commercialization of treatments for central nervous system (CNS) and neurological disorders. The company offers a diverse portfolio of therapies targeting conditions such as ADHD, depression, epilepsy, schizophrenia, and migraine. Brainwave Healthcare utilizes a proprietary polymer-based, modified release technology to optimize drug delivery and improve patient outcomes through better dose titration. Key products in its portfolio include Antipulse (methylphenidate) for ADHD and DayDawn, a specialized nutraceutical for metabolic and neurological health. The company focuses on innovation, quality, and regulatory compliance to address significant unmet needs in the CNS therapeutic space.